Gregory J. Flesher
2021 - Reneo Pharmaceuticals
In 2021, Gregory J. Flesher earned a total compensation of $5.4M as Chief Executive Officer and President at Reneo Pharmaceuticals, a 3,939% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,700 |
|---|---|
| Option Awards | $4,196,725 |
| Salary | $475,000 |
| Stock Awards | $429,699 |
| Other | $48,346 |
| Total | $5,369,470 |
Flesher received $4.2M in option awards, accounting for 78% of the total pay in 2021.
Flesher also received $219.7K in non-equity incentive plan, $475K in salary, $429.7K in stock awards and $48.3K in other compensation.
Rankings
In 2021, Gregory J. Flesher's compensation ranked 2,396th out of 12,405 executives tracked by ExecPay. In other words, Flesher earned more than 80.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,396 out of 12,405 | 81st |
Division Manufacturing | 947 out of 5,494 | 83rd |
Major group Chemicals And Allied Products | 360 out of 2,369 | 85th |
Industry group Drugs | 312 out of 2,090 | 85th |
Industry Pharmaceutical Preparations | 204 out of 1,537 | 87th |
Source: SEC filing on April 22, 2022.
Flesher's colleagues
We found two more compensation records of executives who worked with Gregory J. Flesher at Reneo Pharmaceuticals in 2021.
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019